White Light Scanning to Aid Body Contouring: A Pilot Project
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01093950|
Recruitment Status : Recruiting
First Posted : March 26, 2010
Last Update Posted : October 9, 2014
|Condition or disease|
|Lipodystrophy Body Dysmorphic Disorders|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||White Light Scanning to Aid Body Contouring: A Pilot Project|
|Study Start Date :||January 2005|
|Estimated Primary Completion Date :||August 2020|
|Estimated Study Completion Date :||October 2020|
PROSPECTIVE BODY CONTOURING SUBJECTS
It is anticipated that the participants will undergo body contouring procedures including lipoplasty [internal fat suction removal], abdominoplasty [surgical removal of lower abdominal skin and fat], breast reduction [surgical removal of breast skin, fat, and breast tissue to reduce breast size], breast augmentation [surgical breast enlargement], thigh lift [surgical removal of upper thigh tissue], and brachioplasty [surgical removal of upper arm tissue].
These procedures will be evaluated by pre- and post-operative digital scans, analog measurements, and clinical examinations and photographs.
- To study whether the scanner was faster and more accurate than anthropometric measurements. [ Time Frame: 9 months ]The scanner and anthropometric measurements will be compared for accuracy and fidelity of collection. Anthropometric tape measurements will be compared to measurement extraction profiles provided by the scanner.Conclusions will be drawn based on the data collected.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01093950
|Contact: DAVID A GILBERT, MD||757-274-4000||Dagilb3@msn.com|
|Contact: ROBERT H SCHNARRS, MD||757-274-4000||HAGUE400@AOL.COM|
|United States, Virginia|
|The Hague Center||Recruiting|
|Norfolk, Virginia, United States, 23510|
|Contact: David A Gilbert, MD 757-274-4000 email@example.com|
|Principal Investigator: David A. Gilbert, MD|
|Principal Investigator:||David A Gilbert, MD||Eastern Virginia Medical School|